Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746565
Title: Investigation into pathological neuronal-myeloid cell interactions and rescue of hyper-reactive immune responses in Huntington's disease
Author: Dobson, L.
ISNI:       0000 0004 7224 5963
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
The innate immune system is known to play a significant role in the pathogenesis of Huntington’s disease (HD). However, whether the myeloid cell activation and inflammation associated with neurodegeneration and disease progression in HD is protective or damaging remains to be clearly defined. Here, neuronal-myeloid cell interactions were examined in novel co-culture models of HD, with the aim of investigating the contribution of myeloid cells to neurotoxicity or neuroprotection in the pathogenesis of HD. HD and non-HD human NSC-derived neuronal cell lines expressing human huntingtin (HTT; full-length or exon 1) were developed and characterised. These cell lines can be differentiated into mature neuronal cultures, and HD neuronal cultures expressing mutant HTT exon 1 exhibit several characteristics of pathologically affected neurons in the HD patient brain. Additionally, a novel technique was discovered for the induced differentiation of primary blood monocyte cultures, from healthy volunteers or HD patients, into microglia-like cells (BMD-microglia). BMD-microglia are similar to human brain-resident microglia in vivo by both morphological and antigenic criteria. In co-culture, BMD-microglia rescued HD neurons from mutant HTT-induced neurotoxicity and reduced neuronal death. This was associated with elevated levels of brain-derived neurotrophic factor (BDNF) release and M2 polarisation shift. During chronic stimulation, HD patient BMD-microglia became more M2-polarised than healthy volunteer BMD-microglia and released BDNF at three-fold higher levels. In contrast, BMD-macrophages, differentiated from primary monocyte cultures from healthy volunteers or HD patients, were neurotoxic in co-culture with HD or non-HD neurons, and this was associated with increased release of the proinflammatory cytokines interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)α. Inherent dysfunctional upregulation of cytokine release was also demonstrated in HD patient monocytes. Overall, the findings presented in this Thesis highlight myeloid cell phenotypes as an important modulator of neurotoxicity in HD, and harnessing the innate immune system in order to promote neuroprotective myeloid cell phenotypes whilst inhibiting neurotoxic phenotypes is an attractive therapeutic target. Laquinimod, a novel immunomodulatory drug which has been shown to have beneficial effects in multiple sclerosis patients, was shown here to dampen hyper-reactive cytokine production in HD patient monocytes. Modulation of peripheral immune responses has previously been demonstrated to impact on central pathology and disease progression in HD, and therefore laquinimod may be a promising candidate for dampening the harmful effects of a dysfunctional innate immune system in HD.
Supervisor: Tabrizi, S. J. ; Pocock, J. M. Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.746565  DOI: Not available
Share: